Bios_Illustration_B_RGB_large.jpg

CODE THE BODY CAN RUN

Creating the programming language for lifelong health

BIOS IT4 DATASET

Visualisation by Andreas Nicolas Fischer

arrow.png

BIOS has launched a flagship programme to realise a neural-cardiac therapy in partnership with the top pharma R&D, academic and technology organisations in the world.

AUTONOMIC

THERAPY INITIATIVE

Panel_1-BG.jpg
Panel_1_divider.png
 
 
Panel_2_BG.png

CARDIAC DISEASE IS OUR BIGGEST HEALTH CRISIS WITH FEW EFFECTIVE DRUGS

Cardiovascular diseases are responsible for a third of all deaths globally.

However, new cardiovascular disease therapies are very rare due to the high cost and long timescale of trials and the 10,000 to 1 failure rate of new pharmaceutical compounds.

panel_2_divider.png

OUR BEACHHEAD WILL BE

TO SURPASS THE BETA BLOCKER FOR CARDIAC DISEASE

By understanding and correcting signals in real time, we can treat chronic cardiac illnesses in an effective, automated and personalized way.

Neural interfaces can be used to form a direct connection with the neurons around the heart and other organs, which offers a whole new class of treatments for cardiovascular disease.

Panel_3_BG.jpg
Panel_4_BG.jpg

WHEN WE CAN CONTROL OUR NEURAL SIGNALS WE CAN PREVENT THE DETERIORATION IN OUR HEALTH

ECG

Lines_ECG.png

RESPIRATORY PRESSURE

Lines_BP.png

BLOOD GLUCOSE

Lines_Respiratory.png
 
Panel_4_Connectors_2.png
lines_bg.jpg

THE AUTONOMIC THERAPY INITIATIVE IS POWERED BY DIGITAL NEURAL BIOMARKERS

BIOS uses neural interfaces & AI to discover the language of the nervous system - a code known as digital neural biomarkers

The Autonomic Therapy Initiative (ATI) leverages these unique neural biomarkers to offer precision unseen before in healthcare - giving personalised, real-time treatment recommendations, shaping the design of new therapies and even replacing current drugs with computer generated neural signals

Panel_5_BG.jpg

ATI LEADERSHIP

Team_emil.png

EMIL HEWAGE

BIOS CEO & Founder

Team_Oliver.png

OLIVER ARMITAGE

BIOS CSO & Founder

Team_Joanne.png

PROF. JOANNE HACKETT

BIOS Board Chair

 

ATI ADVISORY PANEL

Team_Tim.png

PROF. TIM DENISON

Royal Academy of Engineering Chair in BioEngineering at the University of Oxford

(Advisory Panel Chair)

Logo_Oxford.png
Team_David.png

PROF. DAVID PATERSON

Head of Dept of Physiology, Anatomy & Genetics at the University of Oxford

Logo_Oxford.png
Team_Mona.png

MONA FLORES MD

Global Head of Medical AI

at Nvidia

Logo_Nvidia.png
Team_Cam.png

DR. CEM BAYDAR

Head of Portfolio Strategy & Consulting Services at IQVIA

Logo_IQVIA.png
team_panel_BG.jpg

Our vision is a future where we have control over our bodies and lives, enabling radically improved, seamlessly experienced healthcare.

DIGITAL NEURAL
BIOMARKERS
THOUSANDS OF POSSIBLE
TREATMENTS
Panel_6_Divider.png
 

Interested in collaborating or learning more about the ATI programme?

Contact us at info@BIOS.health

or fill in the form opposite.

Interested in working with us? 

Take a look at our current vacancies or contact us at careers@BIOS.health

Privacy Policy - Terms and Conditions - Financial Conflicts of Interest Policy

THANK YOU FOR YOUR MESSAGE

 
Real Ventures.png
partner_logo_medteq.png
partner_logo_partenar.png
Logo_Nvidia_footer.png
Y Combinator.png
Cambridge University.png
Mcgill University.png
Healthy Brains For Healthy Lives.png